ABSTRACT. We recently found that certain canine live attenuated vaccines produced using 'non-feline' cell lines were contaminated with an infectious feline endogenous retrovirus, termed RD-114 virus. We suspected that RD-114 virus may have contaminated the seed stock of canine parvovirus (CPV) during the production of the contaminated vaccines. In this study, we collected stock viruses of CPVs propagated in a feline cell line, and checked the presence of infectious RD-114 virus. Consequently, we found that RD-114 viral RNA was present in all stock viruses, and 7 out of 18 stock viruses were contaminated with infectious RD-114 virus. We also found that RD-114 virus was stable physically and is capable of retaining its infectivity for a long period at -80C.
The genomes of mammalian species contain enormous copies of endogenous retroviruses (ERVs). In general, ERVs are not pathogenic in their original hosts; however, once an infectious ERV infects a new host, it may behave as an exogenous retrovirus and induce diseases. For example, gibbon ape leukemia virus that induces lymphoma in gibbons is considered to be derived from ERVs of Asian rodents (Mus caroli, Mus cervicolor and Vandeleuria oleracea) [13] . Therefore, contamination of infectious ERVs in biological products, such as live attenuated vaccines, should be avoided.
The domestic cat genome contains an infectious ERV, termed RD-114 virus [2, 3] . Because RD-114 virus productively infects canine cell lines and primary canine cells in vitro [16] , it is possible that RD-114 virus may infect dogs as an exogenous retrovirus, if the virus is inoculated to dogs. Many live attenuated vaccines for dogs and cats are produced using feline cell lines, such as Crandell-Rees feline kidney (CRFK) cells which produce RD-114 virus [2, 8, 14] . We previously reported that a proportion of canine and feline live attenuated vaccines produced using feline cell lines was in fact contaminated with infectious RD-114 virus [4] . The National Veterinary Assay Laboratory, (Kokubunji, Tokyo, Japan) also confirmed this incidence independently [7] . Furthermore, we recently found that two canine live attenuated vaccines produced using 'non-feline' cell lines were contaminated with infectious RD-114 virus [15] .
Given that these canine vaccines contained the original antigenic type of canine parvovirus (CPV) type 2 in common, and that many such CPVs have been isolated and attenuated using CRFK cells [1, 5] , we suspected that RD-114 virus may have contaminated the seed stock virus for the production of the vaccines [15] . In this study, we collected CPVs from a diagnostic laboratory and American Type Culture Collection (ATCC), and checked for the presence of infectious RD-114 virus. Consequently, we found that a proportion of the stock viruses was contaminated with infectious RD-114 virus.
TE671 cells (human rhabdomyosarcoma) [11] , TE671 cells persistently infected with RD-114 virus (TE671/RD cells) [12] , TE671 cells and G355-5 cells transduced with nlsLacZ gene (termed TE671(LacZ) cells and G355-5(LacZ) cells, respectively [8] ), CRFK cells, and G355-5(LacZ) cells inoculated with a supernatant of CRFK cells (G355-5(LacZ)/CRsup) were cultured in Dulbecco's modified Eagle's medium (Sigma-Aldrich, St. Louis, MO, U.S.A.) supplemented with 10% heat-inactivated fetal calf serum, penicillin (100 units/ml) and streptomycin (100 µg/ ml) (Invitrogen, Carlsbad, CA, U.S.A.).
Thirteen CPV2a and five CPV2b stock viruses, which had been propagated in CRFK cells, were obtained from the Laboratory of Clinical Microbiology, Kyoritsu Seiyaku Corporation, originally for the study of carnivores parvoviruses [10] . These CPVs were isolated from fecal samples of CPV-infected dogs between 1991 and 2003 and the stock viruses were propagated using CRFK cells (Table 1) . CPV2 strain Cornell-780916, which is the parental CPV2 in manufacturing several commercial live vaccines, was also obtained from ATCC (catalogue number: VR-953). This strain may have been propagated in CRFK cells during attenuation [1] ; however, the detailed passage history is unknown. The stock viruses were stored at -80 ºC until use.
RNA was isolated from CPV stock virus using a QIAamp viral RNA mini kit (QIAGEN Inc., Valencia, CA, U.S.A.).
To exclude contamination of cellular DNA from CPV stock viruses, the samples were treated with DNaseI (Roche Diagnostics GmbH, Mannheim, Germany). cDNA (21 l) was synthesized from 150 ng RNA using SuperScript III Reverse transcriptase (Invitrogen). To detect RD-114 viral RNA in CPV stock viruses, an env region of the RD-114 virus was amplified by PCR using 1 l of the synthesized cDNA as described below. Total genomic DNA was isolated from cells using a QIAamp DNA Blood Mini Kit (QIAGEN Inc.). To detect RD-114 provirus, partial RD-114 proviral DNA was amplified using primers corresponding to part of the env gene (forward primer, 5'-ccctcgatactaagagagtg-3'; reverse primer, 5'-acttcagctaacgagtctac-3'). The reaction mixture (25 µl) for the polymerase chain reaction (PCR) was as follows; 1 µl DNA template (100 ng), 2.5 µl of 10×buffer containing 20 mM MgCl 2 (Ex Taq buffer; TaKaRa, Ohtsu, Shiga, Japan), 0.125 µl of Ex Taq (TaKaRa), 2 µl of 2.5 mM deoxynucleotide triphosphates, 0.5 µl of each primer (10 µM) and 18.375 µl distilled water. The amplification conditions were 94°C for 10 min followed by 45 cycles of amplification, consisting of denaturation at 94°C for 30 sec, annealing at 60.3°C for 30 sec, and extension at 72°C for 30 sec, and then final extension at 72°C for 10 min. PCR was carried out in 200 μl thin-walled tubes using a C1000 Thermal Cycler (BIO-RAD, Hercules, CA, U.S.A.).
Several CRFK cells have been reported to produce infectious RD-114 virus [2, 8, 14] . Except for the CPV2 strain Cornell-780916, all CPV isolates used in the present study had been propagated in CRFK cells by a third party and were used for research purposes within the company, not as seed stocks for vaccine production.
To address the possible issue of RD-114 virus contamination, we first tested whether RD-114 viral RNA was present in the stock viruses. Partial RD-114 env was amplified from RNAs extracted from the stock viruses by RT-PCR. As a result, the env sequence was detected in all of the stock viruses obtained from the third party, but not in the CPV2 strain Cornell-780916 (Fig. 1A, 1C) . The amplicons originated from RNA, and not cellular DNA, as PCRs that had not been reverse-transcribed gave no detectable bands (Fig.  1B, 1C) .
We then tried to detect infectious RD-114 virus in the stock viruses by the LacZ marker rescue assay and the receptor interference assay [9] using TE671(LacZ) and TE671/RD cells (Fig. 2) . Twenty-six days after inoculation, we detected replication-competent retroviruses which interfered with the reference RD-114 virus in three (Nos. 2, 3 and 4) out of 18 samples tested. Moreover, forty days after inoculation, we detected replication-competent retroviruses which interfered with the reference RD-114 virus in additional four samples (Nos. 1, 13, 16 and 17). The results were confirmed by detecting RD-114 provirus in genomic DNA extracted from stock virus-inoculated cells (Fig. 2) . In addition, we could not detect infectious RD-114 virus in the CPV2 strain Cornell-780916 (Fig 2) .
Previously, we reported that a pseudotype virus of porcine endogenous retrovirus subgroup A was labile against freeze/thaw treatments [6] . To know the physical stability of the RD-114 virus, we titrated RD-114 virus after repeated freeze/thaw treatments. LacZ(RD-114) virus, which has an envelope and core of RD-114 virus and a nlslacZ gene as a marker, was prepared from the culture supernatant of G355-5(LacZ)/CRsup cells. LacZ(RD-114) viruses were frozen at -80ºC and then thawed at room temperature. This procedure was repeated one to three cycles as indicated in Fig. 3 . In addition, the virus was incubated at 37ºC for 1 hr to test heat stability. The titers of these LacZ(RD-114) viruses were determined by the LacZ assay [9] . By comparing the titers of freeze/thaw treated RD-114 viruses, RD-114 virus was found to be stable and robust (Fig. 3) . In addition, by incubation at 37ºC for one hr, the titer of RD-114 virus was not reduced significantly (Fig. 3) . These data suggested that RD-114 virus is physically stable and may retain its infectivity for a long period at -80ºC. Actually, several CPV stock viruses, which had been stored for 19 years, still contained infectious RD-114 viruses.
In this report, although the RD-114 virus RNA was detected in all of the stock viruses derived from the third party, only seven out of 18 samples were contaminated with 'infectious' RD-114 virus. In addition, infectious RD-114 virus in several CPV stock viruses (Nos. 1, 13, 16 and 17) could not be detected unless the stock virus-inoculated cells were cultured for a long period. We suspect that the amounts of infectious RD-114 virus produced from CRFK cells may vary depending on the condition of the cells.
In our previous report [15] , one canine live attenuated vaccine produced using 'non-feline' cell lines, which had been manufactured using CPV2 strain Cornell-780916, was contaminated with RD-114 viral RNA and 'infectious' RD-114 virus. However, the CPV2 strain Cornell-780916 obtained from ATCC was not contaminated with infectious Table 1. CPV strains used in this study   Sample name  Genotype  Isolation year   1  2a  1991  2  2a  1991  3  2a  1991  4  2a  unknown  5  2a  unknown  6  2a  unknown  7  2a  1992  8  2a  1992  9  2a  1992  10  2b  unknown  11  2a  1998  12  2a  1998  13  2b  1999  14  2b  2000  15  2b  2000  16  2b  2000  17  2a  2000  18  2a ." In this study, we demonstrated that a proportion of CPV stock viruses propagated in a feline cell line was contaminated with infectious RD-114 virus. Given that RD-114 virus replicates well in both feline and non-feline cell lines [8, 15, 16] , it is of upmost importance to use RD-114 virus-free seed stock viruses and RD-114 virus non-producer cell lines in order to avoid contamination in live attenuated vaccines.
